Monthly Archives: December 2014

Biopharmaceutical News Week 51 2014/

  We wish our readers and followers a great holiday season and a happy and successful Year 2015   General December 15, 2014  FDA has approved 35 new drugs so far this year, compared to 27 last year “Our Center for Drug Evaluation and Research (CDER) has so far approved 35 novel drugs in 2014 […]

read more

Biopharmaceutical News Week 50 2014

      Annoucement December 10, 2014  A New President at the European Federation of Pharmaceutical Industries and Associations (EFPIA) Sanofi head Chris Viehbacher resigned as EFPIA boss at the end of October. Joe Jimenez, Novartis’ CEO, has been officially unveiled as President of EFPIA until June 2017   Acquisitions /Mergers/Joint-ventures December 8, 2014  Merck  acquires Cubist […]

read more

Biopharmaceutical News Week 49 2014

    Pharma Re-organisation December 2, 2014  Sanofi agrees with Evotec in a 250 million euro drug discovery alliance Sanofi is in talks with German Biotech Evotec about a five-year “multi-component strategic alliance” that would be worth at least 250 million euros for Evotec. As part of the agreement, Evotec would take over Sanofi's R&D […]

read more

Biopharmaceutical News Week 48 2014

    Management Shake-up in Pharma This was a month a major management shake-up. End of October Sanofi announced that it had ousted Chris Viehbacher. Earlier this week news came that Ulf Wiinberg, CEO of Lundbeck, resigned from his position because of a breach of company’s code conduct. Then Takeda announced the departure of Doug […]

read more